HYDROXYUREA Side Effects

6966777-6 | Ageusia, Alopecia, Dry Eye, Dry Mouth, Fatigue, Headache, Pruritus, Vertigo
on Sep 01, 2010 Female patient from SWITZERLAND , 79 years of age, was diagnosed with thrombocytosis, essential thrombocythaemia and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, alopecia, dry eye, dry mouth, fatigue, headache (What is headache?), pruritus, vertigo. Hydroxyurea dosage: 1-3tablets/d.

6962235-3 | Cough, Lung Disorder, Wheezing
Patient was taking Hydroxyurea (View Usage). Patient had the following side effects: cough, lung disorder, wheezing on Sep 01, 2010 from UNITED STATES Additional patient health information: Male patient , 95 years of age, weighting 173.1 lb, was diagnosed with polycythaemia and. Hydroxyurea dosage: 1000 Mg Every Day Po.

6881475-5 | Alveolitis, Atrial Fibrillation, Lung Infiltration, Tachyarrhythmia
Adverse event was reported on Jul 23, 2010 by a Female patient taking Hydroxyurea (View Usage) (Dosage: 26may) was diagnosed with essential thrombocythaemia and. Location: GERMANY , 80 years of age, weighting 145.5 lb, After Hydroxyurea was administered, patient had the following side effects: alveolitis, atrial fibrillation (What is atrial fibrillation?), lung infiltration, tachyarrhythmia. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

6860069-1 | Kaposi's Sarcoma
on Jul 13, 2010 Male patient from PORTUGAL , 84 years of age, was diagnosed with chronic myelomonocytic leukaemia and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: kaposi's sarcoma (What is kaposi's sarcoma?). Hydroxyurea dosage: . During the same period patient was treated with EPOGEN (View Epogen Review and Epogen Label ).


6759555-4 | Alveolitis, Pleurisy, Urinary Tract Infection
on Jun 02, 2010 Female patient from GERMANY , 80 years of age, was diagnosed with essential thrombocythaemia and was treated with Hydroxyurea (View Usage). Patient had the following side effects: alveolitis, pleurisy, urinary tract infection (What is urinary tract infection?). Hydroxyurea dosage: . Patient was hospitalized.

6734737-6 | Chills, Platelet Count Decreased, Pyrexia
Patient was taking Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: chills, platelet count decreased, pyrexia on May 19, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 126.0 lb, was diagnosed with essential thrombocythaemia and. Hydroxyurea dosage: 500 Mg 2 Am 1 Pm.

6720583-6 | Platelet Count Increased
Adverse event was reported on Apr 26, 2010 by a Female patient taking Hydroxyurea (View Usage) (Dosage: 500 Mg, Qd, Oral) was diagnosed with essential thrombocythaemia and. Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: platelet count increased. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6719372-8 | Neuropathy Peripheral
on May 07, 2010 Male patient from GERMANY , 63 years of age, weighting 180.8 lb, was diagnosed with polycythaemia vera, depression (What is depression?) and was treated with Hydroxyurea (View Usage). Patient had the following side effects: neuropathy peripheral. Hydroxyurea dosage: 1 Df=1 To 2g. During the same period patient was treated with HYDREA (View Hydrea Review and Hydrea Label ), ASPIRIN (1df-100 Unit Nos) (View Aspirin Review and Aspirin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ).

6718298-3 | Aldolase Increased, Dermatomyositis, Disease Complication, Disease Progression, Dry Skin, Erythema, Hypergammaglobulinaemia, Myelodysplastic Syndrome, Photosensitivity Reaction
on Apr 20, 2010 Female patient from UNITED STATES , 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: aldolase increased, dermatomyositis, disease complication, disease progression, dry skin, erythema, hypergammaglobulinaemia, myelodysplastic syndrome, photosensitivity reaction. Hydroxyurea dosage: . During the same period patient was treated with METORPROLOL (METOPROLOL) (View Metorprolol (metoprolol) Review and Metorprolol (metoprolol) Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), TRIAMTERENE (TRIAMTERENE) (View Triamterene (triamterene) Review and Triamterene (triamterene) Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), PAROXETINE MESILATE (PAROXETINE MESILATE) (View Paroxetine Mesilate (paroxetine Mesilate) Review and Paroxetine Mesilate (paroxetine Mesilate) Label ).

6707128-1 | Actinic Keratosis, Rash Macular, Squamous Cell Carcinoma
Patient was taking Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: actinic keratosis, rash macular, squamous cell carcinoma on Apr 29, 2010 from GERMANY Additional patient health information: Female patient , 66 years of age, weighting 172.0 lb, was diagnosed with polycythaemia vera and. Hydroxyurea dosage: Taken Approximately For 4 To 5 Years.

6706091-7 | Palpitations
Adverse event was reported on Apr 16, 2010 by a Female patient taking Hydroxyurea (View Usage) (Dosage: 500 Mg, Bid, Oral) was diagnosed with polycythaemia vera and. Location: UNITED STATES , 80 years of age, Patient had the following side effects: palpitations. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6696154-7 | Atrial Flutter, Coma, Respiratory Depression
on Apr 21, 2010 Female patient from GERMANY , 67 years of age, was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: atrial flutter, coma, respiratory depression. Hydroxyurea dosage: . During the same period patient was treated with FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ). Patient was hospitalized.

6690680-2 | Oedema Peripheral
on Dec 15, 2009 Female patient from UNITED STATES , 74 years of age, was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral. Hydroxyurea dosage: .

6682515-9 | Pyoderma Gangrenosum
Patient was taking Hydroxyurea (View Usage). Patient had the following side effects: pyoderma gangrenosum on Apr 14, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with chronic myeloid leukaemia and. Hydroxyurea dosage: 500 Mg Bid Po. Patient was hospitalized.

6609594-9 | Hepatitis, Porphyria Non-acute
Adverse event was reported on Feb 17, 2010 by a Female patient taking Hydroxyurea (View Usage) (Dosage: ) . Location: MOROCCO , 81 years of age, After Hydroxyurea was administered, patient had the following side effects: hepatitis (What is hepatitis?), porphyria non-acute. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

6558166-3 | Acute Biphenotypic Leukaemia
on Jan 25, 2010 Female patient from UNITED STATES , 78 years of age, was diagnosed with essential thrombocythaemia and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: acute biphenotypic leukaemia. Hydroxyurea dosage: .

6533067-5 | Sickle Cell Anaemia With Crisis, Treatment Noncompliance
on Jan 07, 2010 Female patient from UNITED STATES , 19 years of age, was treated with Hydroxyurea (View Usage). Patient had the following side effects: sickle cell anaemia with crisis, treatment noncompliance. Hydroxyurea dosage: . During the same period patient was treated with EXJADE (View Exjade Review and Exjade Label ). Patient was hospitalized.

6530461-3 | Open Wound
Patient was taking Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: open wound on Jan 06, 2010 from UNITED STATES Additional patient health information: Female patient , 71 years of age, weighting 159.0 lb, . Hydroxyurea dosage: 500 Mgs 1 X Daily.

6525401-7 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Hepatic Function Abnormal, Mouth Ulceration, Myelofibrosis
Adverse event was reported on Dec 16, 2009 by a Female patient taking Hydroxyurea (View Usage) (Dosage: 750 Mg, 1x/day:qd, Oral) was diagnosed with essential thrombocythaemia and. Location: UNITED KINGDOM , 63 years of age, weighting 129.0 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, hepatic function abnormal, mouth ulceration, myelofibrosis. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (75 Mg, 1x/day:qd, Oral) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), 422 (ANAGRELIDE) (422 (ANGAGRELIDE)) CAPSULE (0.5 Mg, 1x/day:qd, Oral) (View 422 (anagrelide) (422 (angagrelide)) Capsule Review and 422 (anagrelide) (422 (angagrelide)) Capsule Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6521540-5 | Malignant Neoplasm Progression, Pancytopenia
on Dec 17, 2009 Male patient from UNITED KINGDOM , 67 years of age, weighting 172.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with Hydroxyurea (View Usage). Patient had the following side effects: malignant neoplasm progression, pancytopenia. Hydroxyurea dosage: . Patient was hospitalized.

6517750-3 | Malignant Neoplasm Progression, Pancytopenia
on Dec 17, 2009 Male patient from UNITED KINGDOM , 67 years of age, weighting 172.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: malignant neoplasm progression, pancytopenia. Hydroxyurea dosage: . Patient was hospitalized.

6502237-4 | Anaemia, Basal Cell Carcinoma
Patient was taking Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, basal cell carcinoma on Dec 09, 2009 from GERMANY Additional patient health information: Female patient , 76 years of age, weighting 154.3 lb, was diagnosed with essential thrombocythaemia and. Hydroxyurea dosage: 500 Mg, 1 Or 3 Capsules Per Day - As Required, Oral. During the same period patient was treated with 422 (ANAGRELIDE) CAPSULE (0.5 Mg, 1 Or 3 Capsules Per Day - As Required, Oral : 0.5 Mg, 1 Or 6 Capsules Per Day - As Required,) (View 422 (anagrelide) Capsule Review and 422 (anagrelide) Capsule Label ), ACETYLSALICYLIC ACID (100 Mg, 1x/day:qd,oral) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), XIPAMID (XIPAMIDE) (View Xipamid (xipamide) Review and Xipamid (xipamide) Label ), BISPROLOL (View Bisprolol Review and Bisprolol Label ), OMEP (OMEPRAZOLE) (View Omep (omeprazole) Review and Omep (omeprazole) Label ). Patient was hospitalized.

6442894-4 | Pericardial Haemorrhage
Adverse event was reported on Nov 12, 2009 by a Male patient taking Hydroxyurea (View Usage) (Dosage: Increased To 2g/day) . Location: TURKEY , 57 years of age, Patient had the following side effects: pericardial haemorrhage. During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6438102-0 | Dizziness, Nausea, Somnolence, Suicide Attempt
on Nov 02, 2009 Male patient from GERMANY , 33 years of age, was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: dizziness (What is dizziness?), nausea (What is nausea?), somnolence, suicide attempt. Hydroxyurea dosage: 100 Tablets,intake Not Assured.. During the same period patient was treated with IBUPROFEN (50 Tablets Ibuprofen 600, Intake Not Assured.) (View Ibuprofen Review and Ibuprofen Label ), ALCOHOL (View Alcohol Review and Alcohol Label ), ALLOPURINOL (100 Tablets Allopurinol 300, Intake Not Assured) (View Allopurinol Review and Allopurinol Label ), GLEEVEC (90 Tablets Glivec 400, Intake Not Assured.) (View Gleevec Review and Gleevec Label ), PANTOPRAZOLE SODIUM (65 Tablets Pantozol 40, Intake Not Assured.) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PAROXETINE HCL (100 Tablets Paroxetin 20, Intake Not Assured.) (View Paroxetine Hcl Review and Paroxetine Hcl Label ).

6431152-X | Impaired Healing, Necrosis
on Nov 03, 2009 Female patient from GERMANY , 81 years of age, was diagnosed with polycythaemia vera and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: impaired healing, necrosis. Hydroxyurea dosage: .

6430092-X | Pericardial Haemorrhage
Patient was taking Hydroxyurea (View Usage). Patient had the following side effects: pericardial haemorrhage on Nov 02, 2009 from TURKEY Additional patient health information: Male patient , 57 years of age, . Hydroxyurea dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).

6405365-7 | Foot Fracture, Osteoporotic Fracture, Stress Fracture, Weight Increased
Adverse event was reported on Oct 16, 2009 by a Female patient taking Hydroxyurea (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 120.0 lb, After Hydroxyurea was administered, patient had the following side effects: foot fracture, osteoporotic fracture, stress fracture, weight increased.

6354555-0 | Abdominal Adhesions, Anastomotic Leak, Bone Marrow Failure, Colon Cancer Stage Iii, Incision Site Erythema, Iron Deficiency, Pelvic Abscess, Peritonitis, Sepsis
on Sep 04, 2009 Female patient from UNITED KINGDOM , 79 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal adhesions, anastomotic leak, bone marrow failure, colon cancer stage iii, incision site erythema, iron deficiency, pelvic abscess, peritonitis, sepsis (What is sepsis?). Hydroxyurea dosage: . During the same period patient was treated with SANDOSTATIN LAR (Route: Injection (nos).) (View Sandostatin Lar Review and Sandostatin Lar Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ). Patient was hospitalized.

6348797-8 | Abdominal Adhesions, Anastomotic Leak, Bone Marrow Failure, Colon Cancer Stage Iii, Incision Site Erythema, Iron Deficiency, Pelvic Abscess, Peritonitis, Sepsis
on Sep 04, 2009 Female patient from UNITED KINGDOM , 79 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Hydroxyurea (View Usage). Patient had the following side effects: abdominal adhesions, anastomotic leak, bone marrow failure, colon cancer stage iii, incision site erythema, iron deficiency, pelvic abscess, peritonitis, sepsis (What is sepsis?). Hydroxyurea dosage: . During the same period patient was treated with SANDOSTATIN LAR (Route: Injection (nos).) (View Sandostatin Lar Review and Sandostatin Lar Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ). Patient was hospitalized.

6314237-8 | Gastric Disorder, Liver Disorder, Oedema Peripheral, Palpitations, Renal Failure
Patient was taking Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: gastric disorder, liver disorder, oedema peripheral, palpitations, renal failure on Aug 04, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 145.0 lb, was diagnosed with bone marrow disorder and. Hydroxyurea dosage: 1000 Mg For 4 Days, Then 1500 Mg For 3 Days Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TEKTURNA /01763601/ (View Tekturna /01763601/ Review and Tekturna /01763601/ Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NU IRON (View Nu-iron Review and Nu-iron Label ).

6311738-3 | Fungal Infection
Adverse event was reported on Aug 13, 2009 by a Female patient taking Hydroxyurea (View Usage) (Dosage: 1 Capsule Daily) was diagnosed with polycythaemia and. Location: UNITED STATES , weighting 145.0 lb, Patient experienced the following unwanted or unexpected effects: fungal infection (What is fungal infection?).

6286936-8 | Clostridium Difficile Colitis, Skin Ulcer
on Jul 23, 2009 Female patient from UNITED STATES , 87 years of age, was treated with Hydroxyurea (View Usage). Patient had the following side effects: clostridium difficile colitis, skin ulcer. Hydroxyurea dosage: . Patient was hospitalized.

6222908-7 | Abdominal Pain, Depressed Mood, Diarrhoea, Fatigue, Nausea, Weight Decreased
on Jun 08, 2009 Female patient from GERMANY , 60 years of age, was diagnosed with polycythaemia vera and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), depressed mood, diarrhoea, fatigue, nausea (What is nausea?), weight decreased. Hydroxyurea dosage: . During the same period patient was treated with LYRICA (Frequency: 1x1 (units Not Provided)) (View Lyrica Review and Lyrica Label ), METOPROLOL SUCCINATE (Frequency: 2x 1/2 (units Not Provided)) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), ATACAND (View Atacand Review and Atacand Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), FENISTIL (View Fenistil Review and Fenistil Label ).

6216427-1 | Dry Gangrene, Fatigue, Hypertension, Impaired Healing, Platelet Count Decreased, Treatment Noncompliance
Patient was taking Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: dry gangrene, fatigue, hypertension, impaired healing, platelet count decreased, treatment noncompliance on Jun 03, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 207.2 lb, . Hydroxyurea dosage: 2500mg Daily.

6206086-6 | Acute Myocardial Infarction, Asthenia, Chromaturia, Dehydration, Dizziness, Hepatic Function Abnormal, Lethargy, Malaise, Paraesthesia
Adverse event was reported on May 25, 2009 by a Male patient taking Hydroxyurea (View Usage) (Dosage: Capsule) . Location: AUSTRALIA , 60 years of age, Patient had the following side effects: acute myocardial infarction, asthenia, chromaturia, dehydration, dizziness (What is dizziness?), hepatic function abnormal, lethargy, malaise, paraesthesia. During the same period patient was treated with ASPIRIN (Tabs) (View Aspirin Review and Aspirin Label ).

6199227-0 | Blood Viscosity Increased, Platelet Count Increased, Red Blood Cell Count Increased
on May 19, 2009 Female patient from UNITED STATES , 75 years of age, weighting 130.0 lb, was diagnosed with polycythaemia vera and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: blood viscosity increased, platelet count increased, red blood cell count increased. Hydroxyurea dosage: 500mg Bid-tid Po.

6197650-1 | Abdominal Pain, Depressed Mood, Diarrhoea, Fatigue, Nausea, Weight Decreased
on May 18, 2009 Female patient from GERMANY , 60 years of age, was diagnosed with polycythaemia vera and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), depressed mood, diarrhoea, fatigue, nausea (What is nausea?), weight decreased. Hydroxyurea dosage: .

6187795-4 | Appendicectomy, Asthenia, Body Temperature Increased, Chills, Cholecystectomy, Haemoglobin Decreased, Malaise, Pain, Pallor
Patient was taking Hydroxyurea (View Usage). Patient had the following side effects: appendicectomy, asthenia, body temperature increased, chills, cholecystectomy, haemoglobin decreased, malaise, pain (What is pain?), pallor on May 11, 2009 from UNITED STATES Additional patient health information: Male patient , 75 years of age, weighting 190.0 lb, was diagnosed with thrombocythaemia and. Hydroxyurea dosage: Bid. Patient was hospitalized.

6154524-X | Depression, Suicidal Ideation
Adverse event was reported on Apr 10, 2009 by a Female patient taking Hydroxyurea (View Usage) (Dosage: Po) was diagnosed with weight control (What is weight control?) and. Location: UNITED STATES , 43 years of age, weighting 222.0 lb, After Hydroxyurea was administered, patient had the following side effects: depression (What is depression?), suicidal ideation.

6145770-X | Alopecia, Hypertrichosis, Keratosis Pilaris, Skin Atrophy, Skin Striae, Spider Naevus
on Mar 26, 2009 Male patient from SENEGAL , 38 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, hypertrichosis, keratosis pilaris, skin atrophy, skin striae, spider naevus. Hydroxyurea dosage: (2.5 G).

6139600-X | Anaemia, Leukopenia, Pyrexia
on Mar 30, 2009 Male patient from UNITED STATES , 81 years of age, was diagnosed with thrombocythaemia and was treated with Hydroxyurea (View Usage). Patient had the following side effects: anaemia, leukopenia, pyrexia. Hydroxyurea dosage: Mg Every Day Po. Patient was hospitalized.

6083602-9 | Hypersensitivity
Patient was taking Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: hypersensitivity on Feb 17, 2009 from GERMANY Additional patient health information: Male patient , 72 years of age, was diagnosed with polycythaemia vera, coronary artery disease (What is coronary artery disease?), osteoarthritis (What is osteoarthritis?), hypertension and. Hydroxyurea dosage: . During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), MELOXICAM (Taken For 8 Months) (View Meloxicam Review and Meloxicam Label ), AMLODIPINE (Taken For More Than 1 Yr) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6046016-3 | Asthenia, Blood Creatine Increased, Depressed Level Of Consciousness, Haemodynamic Instability, Hypoaesthesia, Hypotension, Hypoxia, Pancytopenia, Tachypnoea
Adverse event was reported on Jan 06, 2009 by a Female patient taking Hydroxyurea (View Usage) (Dosage: (500 Mg Bid Oral), (1 G Bid Oral)) was diagnosed with essential thrombocythaemia and. Location: UNITED STATES , 84 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, blood creatine increased, depressed level of consciousness, haemodynamic instability, hypoaesthesia, hypotension, hypoxia, pancytopenia, tachypnoea. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6043683-5 | Pancytopenia, Thrombocytopenia
on Jan 13, 2009 Female patient from UNITED STATES , 84 years of age, was diagnosed with thrombocythaemia and was treated with Hydroxyurea (View Usage). Patient had the following side effects: pancytopenia, thrombocytopenia. Hydroxyurea dosage: Increased To Oral 1 G Bid. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

6025096-5 | Hyperkeratosis, Keratoacanthoma, Nail Pigmentation, Skin Cancer, Skin Lesion, Skin Reaction, Skin Ulcer, Squamous Cell Carcinoma
on Dec 17, 2008 Male patient from ITALY , 81 years of age, weighting 180.8 lb, was diagnosed with anaemia, myelofibrosis, skin cancer (What is skin cancer?) and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: hyperkeratosis, keratoacanthoma, nail pigmentation, skin cancer (What is skin cancer?), skin lesion, skin reaction, skin ulcer, squamous cell carcinoma. Hydroxyurea dosage: (500 Mg Bid). During the same period patient was treated with IMIQUIMOD ((df Topical)) (View Imiquimod Review and Imiquimod Label ), IRON (View Iron Review and Iron Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ).

6006285-2 | Platelet Count Increased, Product Quality Issue
Patient was taking Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count increased, product quality issue on Dec 16, 2008 from UNITED STATES Additional patient health information: Female patient , 71 years of age, weighting 105.0 lb, was diagnosed with thrombocytopenia and. Hydroxyurea dosage: 500mg 1qd Po.

5986266-5 | Chills, Pneumonia, Pyrexia
Adverse event was reported on Dec 04, 2008 by a Female patient taking Hydroxyurea (View Usage) (Dosage: Initiated In Jun08 Suspended In Jul08 Reintroduced On 23sep08) was diagnosed with myeloproliferative disorder, urinary tract infection (What is urinary tract infection?), pneumonia (What is pneumonia?) and. Location: SWITZERLAND , 79 years of age, Patient had the following side effects: chills, pneumonia (What is pneumonia?), pyrexia. During the same period patient was treated with ROCEPHIN (Previously Taken In Jul08(towards The 20jul08)) (View Rocephin Review and Rocephin Label ), AUGMENTIN '125' (Previously Taken From 19jul08 To 29jul08) (View Augmentin '125' Review and Augmentin '125' Label ), NOROXIN (View Noroxin Review and Noroxin Label ). Patient was hospitalized.

5917195-0 | Pain, Pancreatitis
on Oct 13, 2008 Male patient from GERMANY , 76 years of age, weighting 156.5 lb, was diagnosed with thrombocythaemia, type 2 diabetes mellitus and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: pain (What is pain?), pancreatitis. Hydroxyurea dosage: 1 Df - 1 Capsule. During the same period patient was treated with EUGLUCON (1 Dosage Form = 2-3(units Not Specified)) (View Euglucon Review and Euglucon Label ), CARMEN (1 Dosage Form = 1 (units Not Specified)) (View Carmen Review and Carmen Label ), BLOPRESS (1 Dosage Form = 1 (units Not Specified)) (View Blopress Review and Blopress Label ), ASPIRIN (1 Df = 50unit Not Specified.) (View Aspirin Review and Aspirin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CREON (View Creon Review and Creon Label ).

5910713-8 | Back Pain, Musculoskeletal Pain, Paraesthesia
on Oct 06, 2008 Female patient from UNITED STATES , 82 years of age, weighting 114.0 lb, was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), musculoskeletal pain, paraesthesia. Hydroxyurea dosage: One Capsule Daily Po.

5904493-X | Animal Bite, Chills, Dyspnoea, Hypotension, Pyrexia
Patient was taking Hydroxyurea (View Usage). Patient had the following side effects: animal bite (What is animal bite?), chills, dyspnoea, hypotension, pyrexia on Sep 30, 2008 from UNITED STATES Additional patient health information: Male patient , 84 years of age, . Hydroxyurea dosage: 1000 Mg Every Day Po. Patient was hospitalized.